Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Michael F. Mahoney

At a glance: Michael F. Mahoney is CEO, President at Boston Scientific (BSX). Their latest SEC Form 4, filed Aug 5, 2026, reported a purchase of $9.0M. On file: 1 purchase line ($9.0M) and 2 sale lines ($15.0M).

Disclosed holdings: about $67.9M of BSX stock: 1,590,024 shares reported on their latest Form 4 (filed Aug 5, 2026), valued at the Nov 20, 2026 close of $42.72. This counts only BSX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CEO, President at Boston Scientific Corp (BSX)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-8.9%
vs. S&P 500-7.1%
Beat the market0%
Paper profit on buys−$1.0M
Total bought / sold$9.0M / $15.0M

Michael F. Mahoney's InsiderPrint

5 trades from SEC Form 4 filings, 2024 to 2026, drawn as one fingerprint.

InsiderPrint of Michael F. Mahoney: 5 trades, 2024 to 20262024: 1 buy, 0 sales2025: 1 buy, 0 sales2026: 1 buy, 2 sales

Reading this print: Mostly buys, trading about 2 times a year, typically $2.0M a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (3)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Melissa D. SmithCEO, President · WEX · 96% match
  2. Michael H. DavidsonCEO · NAMS · 93% match
  3. Joseph A. CutilloCEO · STRL · 90% match
  4. Vivek ShahCEO · ZD · 90% match
  5. Mark Wayne HobbsEvp, Delek Logistics · DK · 89% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2024

From the SEC's insider data sets: each open-market buy by Michael F. Mahoney, matched to how the stock did over the next 90 days against the S&P 500.

1 of 3 buys beat the S&P 500 (33%), median -0.0% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
BSXAug 7, 2026-4.5%
CVSFeb 19, 2025-0.0%
CVSMay 2, 2024+1.2%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Aug 5SEC BSXBoston Scientific CorpFirst buyPast buys 1/3 beat S&P Buy 186,2401,590,024 held (+13%) $48.33 $9.0M -11.6%
Feb 3SEC BSXBoston Scientific Corp Sell Plan 1,2001,571,436 held (−0%) $94.06 $113K -54.6%
Feb 3SEC BSXBoston Scientific Corp Sell Plan 159,7011,411,735 held (−10%) $93.49 $14.9M -54.3%
  • Buy

    CEO, President Michael F Mahoney bought $9.0M of BSX at $48.33 — first open-market purchase in our records.

  • Sell

    CEO, President Michael F Mahoney sold $113K of BSX at $94.06 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President Michael F Mahoney sold $14.9M of BSX at $93.49 — pre-scheduled 10b5-1 plan sale.

Follow Michael F. Mahoney

Get one email when Michael F. Mahoney files a new purchase or sale. Free.

At most one email a day about Michael F. Mahoney, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.